John Alexander Kelly - 03 Mar 2025 Form 4 Insider Report for PRECISION BIOSCIENCES INC (DTIL)

Role: Chief Financial Officer
Signature: /s/ Dario Scimeca, Attorney-in-fact for John Alexander Kelly
Issuer symbol: DTIL
Transactions as of: 03 Mar 2025
Net transactions value: $0
Form type: 4
Filing time: 05 Mar 2025, 19:00:14 UTC
Previous filing: 22 Jan 2025
Next filing: 04 Jun 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	DTIL	Common Stock	Options Exercise		+1,702	+2%		86,256	03 Mar 2025	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	DTIL	Restricted Stock Units	Options Exercise	$0	-1,702	-100%	$0.000000	0	03 Mar 2025	Common Stock	1,702		Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the vesting of Restricted Stock Units ("RSUs") on March 3, 2025.
F2	Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
F3	On March 3, 2022, the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on March 3, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. The RSUs vested in full on March 3, 2025.